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Abstract
The liver is the primary organ responsible for clearing most drugs from the body and
thus determines systemic drug concentrations over time. Drug clearance by the liver
appears to be directly related to organ size. In children, organ size changes as children
age and grow. Liver volume has been correlated with body surface area (BSA) in
healthy children and adults and has been estimated by functions of BSA. However,
these relationships were derived from “typical” populations and it is unknown whether
they extend to estimations of liver volumes for population “outliers,” such as children
with overweight or obesity, who today represent one-third of the pediatric population.
Using computerized tomography or magnetic resonance imaging, this study measured
liver volumes in 99 children (2–21 years) with normal weight, overweight, or obesity
and compared organ measurements with estimates calculated using an established
liver volume equation. A previously developed equation relating BSA to liver volume
adequately estimates liver volumes in children, regardless of weight status.
Study Highlights
WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC?
Liver anatomy and physiology are key determinants of hepatic drug metabolizing
capacity captured by physiologically-based pharmacokinetic (PBPK) models. Liver
volumes in children with normal weight have been estimated as a function of body surface area (BSA), age, and other anthropometric features. These relationships have not
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been established for children with overweight or obesity, a growing patient population
for whom PBPK modeling could provide valuable new pharmacology knowledge.
WHAT QUESTION DID THIS STUDY ADDRESS?
Are liver volumes in children with overweight or obesity accurately estimated by a
previously published BSA-based equation derived from children with normal weight?
WHAT DOES THIS STUDY ADD TO OUR KNOWLEDGE?
This study demonstrates that liver volumes in children with overweight or obesity can
be accurately estimated using BSA-based equations previously established in children with normal weight, whereas estimations of liver volume as a function of other
parameters, such as age, require corrections for weight status.
HOW MIGHT THIS CHANGE CLINICAL PHARMACOLOGY OR
TRANSLATIONAL SCIENCE?
Accurate estimates of liver volume are critical scalars for predicting hepatic clearance with PBPK models, which are used to help approve and improve pharmaceutical
therapies for children, 30% whom have overweight/obesity. The strong correlation
of liver volumes with BSA across weight strata, paired with a weak correlation with
body mass index z-score, indicates that liver volume increases proportionally with
overall body size (i.e., BSA) not obesity status per se. Our findings suggesting that
separate obesity-specific liver volume equations are not necessary for PBPK model
development, as long as BSA is accounted for.

I N T RO D U C T ION
Prior to the Best Pharmaceuticals for Children Act (BPCA)
in 2002, drugs had not been frequently or extensively investigated in children. Therefore, there remains much to learn
regarding pediatric drug disposition (pharmacokinetics
[PK]) and response (pharmacodynamics [PD]. Additionally,
there are some challenges in fully characterizing pediatric
PK and PD. The pediatric population represents a dynamic
and heterogenous group of patients whose inherent and dynamic characteristics (e.g., age, size, stage of biologic development, and organ maturation) can significantly influence
drug PK and PD. Furthermore, it is often more challenging to conduct pediatric pharmacology trials compared with
adults and investigations may be especially difficult to implement for subpopulations of children, resulting in small
study sample size.1 In such scenarios, computational approaches can be applied to simulate drug concentrations and
responses in children when it is difficult to obtain adequate
data or sample sizes to evaluate the PK/PD of a pharmaceutical agent of interest.1 Physiologically-based pharmacokinetic (PBPK) modeling is one computational approach that
simulates drug concentrations with respect to time and can
be applied across the pediatric age range.2 It has, thus, garnered increased interest and use for pediatric populations.
Currently, pediatric PBPK models are predominately representative of children with normal weight, but nearly 30%
of children in the United States are overweight or obese.3
Due to comorbid conditions, children with overweight and

obesity are more likely to require treatment with medications than normal-weight peers4 and it is therefore necessary
to identify if physiologic model inputs (e.g., organ volumes)
require adjustments in children with overweight or obesity.
Pediatric PBPK models use the expected anatomy and
physiology of children (e.g., organ sizes, blood flows, etc.) in
combination with drug-related properties (e.g., physiochemical characteristics, lipid solubility, enzyme and transporter
kinetics, etc.) to mechanistically simulate the absorption, distribution, metabolism, and elimination of the drug in question.5 These models evolve as pediatric anatomy/physiology
data become available to more accurately capture changes in
physiology over age, disease status, etc., and thus more accurately simulate PK in a broad spectrum of children, including
those with overweight/obesity.
Because the liver is responsible for the elimination of
greater than 70% of drugs,6 anatomic and physiological
changes in the liver expected during the course of childhood
are essential elements for PBPK model development. For
drugs eliminated by hepatic mechanisms (e.g., phase I metabolism), a PBPK model estimates in vivo clearance by applying scaling factors, including microsomal protein per gram
of liver (MPPGL) and liver volume, to the intrinsic clearance
evaluated in an in vitro system (e.g., hepatic microsomes).7
MPPGL values are available from in vitro studies8 and may
vary with factors such as age.8,9 Reliable estimates of liver
volumes in children are needed in PBPK model development
to help estimate hepatic capacity for drug clearance and thus
systemic drug concentrations for children.10–12
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Several studies have evaluated liver volume and mass in
adults and normal-
weight children, and demonstrated that
these important PBPK parameters can be estimated as a function of anthropometric features such as height,13 body mass
index (BMI),14 age,14 and sex.13,14 A meta-analysis of 9 pediatric sources (5036 patients) and 11 models that generated
estimates of pediatric liver volumes using variables, including
body surface area (BSA), age, sex, and weight determined that
liver volume (LV) in children was most accurately estimated
as a function of BSA, which depends on height and weight,
regardless of sex (LV = 0.722*BSA1.176).15 The model also
performed well predicting liver volume in adults compared
to other liver size models in an independent verification.16
However, despite the prevalence of overweight and obesity in
the pediatric population, an algorithm to describe LV has not
been established for these children. Thus, the primary aim of
this study was to assess the applicability of an existing BSA-
based liver volume equation derived from children with normal
weight17,18 to estimate liver volumes measured via magnetic
resonance imaging (MRI) and computerized tomography
(CT) in children with overweight or obesity; the relationship
of liver volumes with other anthropometric descriptors was
also considered for comparison and completeness.

M ET H O D S
Two independently collected datasets of liver volumes and
anthropometric features were collated for this study. Normal
weight, overweight, or obesity status for children was defined
using standard BMI criteria for age and sex.3,19,20

Dataset 1 collection and liver volume
determination
A retrospective chart review of patients aged 2–20 years, who
underwent MRI or CT imaging of the abdomen and were not
known to have conditions that could impact hepatic size or
function (e.g., abdominal tumors and hepatitis) were included
in the study. Using software that searched all radiology reports at our institution (PS360 Montage, Nuance), we identified consecutive MRIs and CTs, which included the whole
abdomen in the field of view from 2010 to 2017. Height,
weight, age, sex, race/ethnicity, and comorbidity information
were collected from a detailed review of the electronic medical record. BMI (kg/m2) was calculated and children were
categorized to have normal weight, overweight, or obesity
based on BMI percentile for age and sex: BMI less than 85th
percentile (normal weight), 85–94th percentile (overweight),
or greater than or equal to 95th percentile (obese).
Z-scores21 were calculated for height, weight, and BMI
for each record. When the absolute value of a z-score was
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greater than 3, the records were examined in the context of
other growth measures for that child and removed if they
were incorrectly recorded.
Images were analyzed in the PACS system (InteleViewer,
Intelerad Medical Systems Incorporated). Axial images from
CT studies and T2 MRI sequences were reviewed and liver
measurements were made with the volume of interest tool.
Liver contours were traced on each axial slice with coronal
and sagittal reformats available for reference. Slice thickness
and skip was interpolated by the volume tool. The inferior
vena cava (IVC) was excluded from measurement when
it could be clearly separated from the adjacent liver parenchyma. When the IVC could not be easily excluded, or in
the case of branch veins, they were included in the measurement. The portal vein was included in the region of interest
measurements in all cases. Regions of interest were drawn to
exclude the hilum (Figure 1).
This study was approved by the institutional review board
at Children’s Mercy Hospital as minimal risk with a waiver
of permission, consent, and assent.

Dataset 2
All procedures for dataset 2 were identical except that all images were acquired from T2 MRI sequences performed for
research purposes in children participating in a prospective
pharmacology trial of proton pump inhibitors in pediatric
obesity (NCT04248335). Liver volumes measured using
tracings of the liver contour on imaging were compared to
liver volumes reported as direct output from the MRI sequence and were within 1% of each other (Figure 1).
This study was approved by the institutional review
board at Children’s Mercy Hospital. Informed consent and
permission/assent were obtained prior to any study-related
procedures.

Analysis
The dataset compositions were compared using a student t-
test for age, and χ2 test for sex, weight class, and distribution
of self-reported race.
Liver volumes measured on imaging were compared to
the volumes estimated from the methods published in the
meta-analysis by Johnson et al.15: BSA was calculated by
the Haycock22 equation for children less than 15 kg, and
the Dubois and Dubois23 equation for children greater than
15 kg and liver volume was calculated as 0.722*BSA1.176.
A twofold difference from estimated values was quantified
and the image-measured liver volumes were compared to
the estimated volumes using twofold error analysis. Image-
measured liver volumes greater than 2-fold or less than
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1/2-fold from the estimated volumes were tallied. The coefficients of variation (CV) of the image-measured liver
volumes compared to the liver volumes estimated by each
subject’s BSA were calculated for each weight group. A
nonlinear regression, analogous to that already published
(LV = A*BSAB), was applied and the coefficients (A and
B) were fit using GraphPad Prism. The extra sum-of-squares
F test was used to determine whether one regression, or regressions specific to each weight class were required. The
nonlinear regressions and analyses were applied to subgroups of children based on commonly employed age bins:
child (6–12 years), adolescent (12–18 years), and young
adult (18–21 years).
The following variables were independently examined for
their ability to estimate liver volume in each weight class:
age, height, weight, BMI, BMI z-
score, lean body mass
(LBM), and fat-free mass (FFM). We also included BSA
calculated following the methods as described by Johnson
et al.15 as a comparator. LBM was calculated using the equation by Peters et al.24 FFM was calculated using the equation
by Al Sallami et al.25 Pearson correlation coefficients were
calculated for each variable as an estimator of liver volume.
Linear equations were fit for each variable using the generalized linear model (glm) function in R Studio as an estimator
of liver volume for the entire dataset and subdivided into normal weight, overweight, and obese datasets. The CVs were
calculated for each equation (composite, normal weight,
overweight, and obese).

RESULTS
Datasets

F I G U R E 1 (a) Axial T2 magnetic resonance (MR) images
through the level of the mid liver from a from a 15 year old girl with
obesity. (b) Axial MR images from the same patient with an overlay
showing an example of the manually drawn contours that were used to
calculate liver volumes. (c) Axial t1 fat saturated MR images from the
same patient at the same level showing the automated contours (white)
that were also used to calculate liver volumes. Note the similarity
between the contours on images in (b) and (c). In a subset of patients
who had both automated and manually contoured liver volumes
available (n = 22), the volumes were within 1% of each other.

Liver volume data were collected for 48 children (ages 2 to
20 years) in dataset 1. Data from six children were removed
due to comorbid conditions that could affect liver size independent of weight status (hepatoblastoma, lymphoma
and hyperbilirubinemia, metastatic leukemia, alpha-
1-
antitrypsin deficiency, Ewing’s sarcoma with rapid weight
loss, and known non-alcoholic fatty liver disease), resulting
in a dataset of 42 patients. Age was available for every patient and height and weight were available for 40 patients
(Figure 2). Twenty of the final images were acquired from
MRI and 22 from CT. MRI and demographic data were
obtained for all 51 subjects (ages 6 to 21 years) in dataset 2. Descriptive statistics for each dataset are reported in
Table 1 and the distribution of the datasets into age bins is
shown in Figure 3.
The datasets were similar with respect to sex and weight
class distribution. Given differences in age inclusion criteria
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F I G U R E 2 Flow of the data available
after liver volumes were collected in the
retrospective study (dataset 1) and the
prospective study (dataset 2). BSA, body
surface area

T A B L E 1 Descriptive statistics of measured liver volumes in
pediatric patients
Set 1

Set 2

n

42

51

% Male

52

49

Ns

Age

11.7 ± 4.6

14.8 ± 3.0

<0.001

Range

2.6–19.1

8.8–20.3

Weight classa

P

Ns

Normal

13

17

Overweight

11

11

Obese

16

23

Non-Hispanic
White

30

27

Black

5

18

Hispanic

4

0

Asian

1

1

Native American

0

0

Pacific Islander

0

2

White/Hispanic

0

1

White/Black

0

2

Multiple race,
unspecified

2

0

Race

<0.05

a

When height and weight were available, n = 40 in dataset 1.

for the 2 studies, dataset 2 had a statistically significantly
higher mean subject age than dataset 1. A significant difference in the distribution of race was also noted between
datasets, with dataset 2 having a higher proportion of Black
participants.

Associations of liver volume with
anthropometric features
BSA and LBM were most highly correlated to liver volume
(Table 2). When linear equations for each anthropometric variable were regressed to image-measured liver volumes, BSA
and LBM had the lowest errors (CVs) and remained among

FIGURE 3
bars)

Age distribution of datasets 1 (black bars) and 2 (grey

the best predictors of liver volume for each weight status
group, with no discernible difference in CV between weight
statuses (Table 2). Additionally, the correlation between BMI
z-score—a continuous indicator of weight status—and liver
volume was weak (0.32–0.47), indicating that liver volume
is not dependent on weight status. With no other anthropometric predictor performing substantially better than BSA
for all weight classes, and a robust meta-analysis previously
establishing a significant relationship between BSA and liver
volume for predominantly normal weight children,15 we evaluated these previously established estimation equations of liver
volume against image-measured volumes from our independent pediatric datasets.
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31

32

22

25

Liver volumes of patients with normal,
overweight, and obesity compared to those
from a reference estimation

a

The Johnson estimate is a nonlinear regression fit by LV (cm3) = 722*BSA1.176.

Abbreviations: BMI, body mass index; BSA, body surface area; CV, coefficient of variation; FFM, fat-free mass; LBM, lean body mass; LV, liver volume.

0.38
23
13
20
25
0.47
28
26
43
0.32
BMI z-score

37

23

20
19

16
25

21
24

28
0.58

0.69
10

23
13

12
20

23
26

22
0.65

0.40
24

24
14

14
23

19
26

29

0.76

0.69

Height (cm)

Age (days)

20

14
17

15
24

19
19

24
0.71

0.83
11

20
10

11
15

20
21

16
0.83

0.68
18

15
12

14
26
0.77

22
19
0.87
Weight (kg)

BMI (kg/m2)

25

18
20
17
18
0.83
15
13
11
15
0.85
20
13
20
0.86
FFM

22

16

15
17

17
18

18
18

18
0.84

0.84
10

10
11

11
15

15
15

15
0.85

0.85
19

18
12

12
20

20

0.88

19
0.88
LBM (kg)

BSA (m2)

19

18
21
16
18
0.84
16
26
12
17
0.85
21
15
20
20

Overweight
Normal
All
R
R
R

All

Normal

Overweight

Obese

CV (%)
CV (%)

All

Normal

Overweight

Obese

CV (%)

Combined Sets
Set 2
Set 1

0.88
Johnson Estimate

a

Variable

TABLE 2

Anthropometric features as estimators of liver volume in children: correlation coefficients and coefficients of variation fit to simple linear regressions for each variable

Obese

LIVER VOLUME IN CHILDREN

All estimations of liver volume using the equation
LV = 0.722*BSA1.176.15 fell within 2-fold of the image-
measured liver volumes (Figure 4). The CVs for the BSA-
estimated liver volumes compared to the image-measured
liver volumes are similar between weight statuses and are
less than 30% (Table 2).
Nonlinear regressions fit to the analogous function
LV = A*BSAB were best fit by a single curve for all weight
classes in dataset 1 (p = 0.86). For dataset 2, the model performed best with different curves for different weight classes
(p = 0.02). However, this was driven by a regression line for
overweight children, which was significantly different from
the regressions for both normal-weight (p = 0.0003) and
children with obesity (p = 0.04), whereas a single curve can
describe the liver volume as a function of BSA for both children with normal weight and children with obesity (p = 0.29;
Figure 5). Nonlinear regressions fit to the analogous function
LV = A*BSAB were best fit by a single curve for all weight
classes when subgroup analysis was applied based on age
bins: 6–12 years (p = 0.61), 12–18 years (p = 0.33), and 18–
21 years (p = 0.38).
There were no significant differences in the above regressions for males and females in dataset 1, whereas boys and
girls were fit by different regressions in dataset 2. In dataset
2, boys had greater liver volume in relation to BSA when
BSA was greater than 1.66, whereas liver volume was greater
in girls with a smaller BSA. Both datasets showed significant differences in the relationships between liver volume
and BSA for White and Black participants. Although dataset
1 showed that at similar BSAs, the liver volume was larger

F I G U R E 4 Measured liver volume versus Johnson estimation of
liver volume with twofold error
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in children who were Black compared to the liver volume
of children who were White, dataset 2 showed that at similar BSAs, the liver volume of children who were White was
larger than the liver volume of children who were Black.
There were no significant differences in liver volume as a
function of BSA in dataset 1 for the liver volumes collected
by CT or by MRI (Figure S1).

DI S C U S S IO N
BSA has been proposed as a measure to estimate liver volume.15,26,27 However, equations estimating liver volumes in
children have thus far not considered weight status, stratified
categorically as normal, overweight, and obese according to
current BMI percentile-based criteria, as a covariate. Studies
in adults suggest that weight status may alter liver volume.
For instance, liver volume significantly decreased with
weight loss in adults following bariatric surgery28 and following a low-or very-low-calorie diet prior to bariatric surgery.29 Our data confirm that the published BSA-dependent
liver volume equation reliably estimates liver volume for
children independent of weight status, with every child in our
dataset having less than twofold error for estimated versus
measured volume (Figures 4 and 5) as well as consistently
low CVs (<30%) across weight strata (Table 2). The strong
correlation of liver volumes with BSA, paired with a weak
correlation with BMI z-score, indicates that liver volume increases proportionally with overall body size (i.e., BSA) not
obesity status per se, suggesting that separate obesity-specific
liver volume equations are not necessary for PBPK model
development. These findings are strengthened by observed
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reliability of the liver volume equation independent of the
measuring image modality used (CT or MRI).
This study also independently evaluated other anthropometric variables as estimators of liver volume in children with
normal weight, overweight, or obesity. Size-related variables,
particularly BSA and LBM, were the most reliable estimators
and superior to age. Although several established models estimate liver volume solely by age,30–33 our results suggest that
when pediatric liver volumes are estimated on the basis of
age alone, adjustments must also be made for weight status
(Figure S2). Moreover, subgroup analysis in commonly used
age groups reaffirmed that liver volume can be adequately estimated by a single regression to BSA, despite weight status.
LBM estimated liver volume with similar reliability to BSA. It
has been suggested that, because metabolic processes are primarily confined to lean tissues, LBM, or FFM may be useful in
understanding the clearance of drugs in children with obesity.
Because LBM is often approximated by FFM, FFM might be a
preferred scalar.25 In the current study, there was little difference
in the reliability of LBM or FFM in estimating liver volume.
Both race12,15,34–36 and sex29 have been reported to significantly impact liver volume. A scaling factor was applied to the
Johnson et al. equation to correct for liver size in a Chinese population,36 but further analysis based on data from Wang et al.37
and Li et al.38 has shown that the scaling factor is only needed
for boys (unpublished results of Pan X, Salem F, Johnson TN,
et al., Certara UK limited, 2020). In our cohort, we could not
confirm that race could affect liver volume in any consistent
manner. In addition, boys have been reported to have larger livers29; however, this appears to be a function of differences in
body composition (i.e., boys have larger LBM or BSA),39 and
when these covariates are accounted for, sex differences are not

F I G U R E 5 Liver volumes versus body surface area (BSA). Dataset 1 (panel a) and dataset 2 (panel b). BSA was calculated using the method
described by Johnson et al. Regression lines are fit to weight class (normal, overweight, or obese) using LV = A*BSAB. The solid line shows the
estimates of liver volume as a function of BSA as published by Johnson et al.15
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apparent.15 We did not observe differences in liver volumes,
when predicted as a function of BSA, for boys versus girls in
dataset 1, whereas boys had larger livers at larger BSAs and
smaller livers at smaller BSAs than girls in dataset 2. Thus, the
primary determinant of liver volume appears to be body size, as
best described by BSA.
A potential limitation of this study is that we assessed liver
volume, as opposed to mass. However, organ volume measurement is readily available in vivo, which is important for
developing clinically applicable PBPK models. Organ volumes have been noted to be good predictors of organ mass
and function, and densities allow conversion from volume
to mass (1.08 for liver). However, it is possible that these
densities may not be consistent across normal, overweight,
and obese weight groups as increases in free fat content in
obese individuals could alter tissue density. As such, further
research into potential variability in organ density as a consequence of obesity is warranted for optimal obesity PBPK
model development.
Drug dosages in children are often prescribed according
to BSA, weight, or LBM.40 It is often uncertain if adjustments
to dosing algorithms need to be made for children with obesity. This study suggests that liver size correlates well with
both BSA and LBM. Because liver size is associated with
drug metabolizing capacity in the liver, it appears that either
measure may appropriately account for liver functionality and
thus hepatic clearance. However, this study was not designed
to address the cellular composition of liver volumes. Excess
deposits of adipose tissue, which may not be as metabolically
active as hepatocytes, may contribute to the volumes of livers
of children with overweight or obesity and thus increases in
metabolic activity may not be directly proportional. However,
weight gain and obesity affect many systems in the body,
where they may exert differential effects and extrapolation of
our observations beyond the liver warrants caution. Because
PBPK models may use liver volumes as critical scalars to estimate drug clearance and concentrations, this study suggests
that liver volume estimations as a function of BSA do not
need adjustment for weight class, whereas estimations as a
function of age may require additional anthropometric input
to accurately estimate drug concentrations in children with
overweight or obesity.

CO NC LU S IO N S
1. The relationship previously developed to estimate liver
volume as a function of BSA (LV = 722*BSA1.176) in
children applies to children of all weight status, including
overweight and obesity.
2. Reliability of this liver volume Equation 2 is replicated across different imaging modalities and volume-
determining methodology.

|

2015

DISCLAIMER
As an Associate Editor of Clinical and Translational Science,
Valentina Shakhnovich was not involved in the review or
decision process for this paper.
CONFLICT OF INTEREST
All authors declared no competing interests for this work.
AUTHOR CONTRIBUTIONS
C.H.C., S.S.C., A.R., N.M., T.N.J., J.S.L., and V.S. wrote
the manuscript. C.H.C., S.S.C., A.R., N.M., J.S.L., and V.S.
designed the research. C.H.C., V.S., C.S.F., A.R., V.W.,
E.S., D.O., J.R., and N.M. performed the research. C.H.C.,
T.N.J., J.S.L., and V.S. analyzed the data.
R E F E R E NC E S

1. Grimstein M, Yang Y, Zhang X, et al. Physiologically based
pharmacokinetic modeling in regulatory science: an update from
the U.S. Food and Drug Administration's Office of Clinical
Pharmacology. J Pharm Sci. 2019;108:21-25.
2. Templeton IE, Jones NS, Musib L. Pediatric dose selection and
utility of PBPK in determining dose. AAPS J. 2018;20:31.
3. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA.
2014;311:806-814.
4. Solmi F, Morris S. Association between childhood obesity and use
of regular medications in the UK: longitudinal cohort study of children aged 5–11 years. BMJ Open. 2015;5:e007373.
5. Jamei M. Recent advances in development and application of
Physiologically-Based Pharmacokinetic (PBPK) models: a transition from academic curiosity to regulatory acceptance. Curr
Pharmacol Rep. 2016;2:161-169.
6. Wienkers LC, Heath TG. Predicting in vivo drug interactions from
in vitro drug discovery data. Nat Rev Drug Discov. 2005;4:825-833.
7. Rostami-Hodjegan A, Tucker GT. Simulation and prediction of in
vivo drug metabolism in human populations from in vitro data. Nat
Rev Drug Discov. 2007;6:140-148.
8. Barter ZE, Chowdry JE, Harlow JR, et al. Covariation of human
microsomal protein per gram of liver with age: absence of influence of operator and sample storage may justify interlaboratory
data pooling. Drug Metab Dispos. 2008;36:2405-2409.
9. Barter ZE, Bayliss MK, Beaune PH, et al. Scaling factors for the
extrapolation of in vivo metabolic drug clearance from in vitro
data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver. Curr Drug Metab.
2007;8:33-45.
10. Jamei M, Dickinson GL, Rostami-Hodjegan A. A framework for
assessing inter-individual variability in pharmacokinetics using
virtual human populations and integrating general knowledge of
physical chemistry, biology, anatomy, physiology and genetics:
a tale of bottom-up vs top-down recognition of covariates. Drug
Metab Pharmacokinet. 2009;24:53-75.
11. Johnson TN, Rostami-Hodjegan A, Tucker GT. Prediction of the
clearance of eleven drugs and associated variability in neonates,
infants and children. Clin Pharmacokinet. 2006;45:931-956.
12. Small BG, Wendt B, Jamei M, Johnson TN. Prediction of liver volume -a population-based approach to meta-analysis of paediatric,

2016

13.

14.

15.

16.

17.

18.

19.

20.

21.

22.

23.

24.
25.
26.

27.

28.

29.

|

  

adult and geriatric populations -an update. Biopharm Drug Dispos.
2017;38:290-300.
Malpique R, Bassols J, Lopez-Bermejo A, et al. Liver volume and
hepatic adiposity in childhood: relations to body growth and visceral fat. Int J Obes (Lond). 2018;42(1):65-71.
Joshi M, Dillman JR, Singh K, et al. Quantitative MRI of fatty
liver disease in a large pediatric cohort: correlation between liver
fat fraction, stiffness, volume, and patient-specific factors. Abdom
Radiol (NY). 2018;l43(5):1168-1179.
Johnson TN, Tucker GT, Tanner MS, Rostami-
Hodjegan A.
Changes in liver volume from birth to adulthood: a meta-analysis.
Liver Transpl. 2005;11:1481-1493.
Pomposelli JJ, Tongyoo A, Wald C, Pomfret EA. Variability of
standard liver volume estimation versus software-assisted total
liver volume measurement. Liver Transpl. 2012;18:1083-1092.
Jackowski C, Thali MJ, Buck U, et al. Noninvasive estimation of
organ weights by postmortem magnetic resonance imaging and
multislice computed tomography. Invest Radiol. 2006;41:572-578.
Tang H, Vasselli JR, Wu EX, Boozer CN, Gallagher D. High-
resolution magnetic resonance imaging tracks changes in organ
and tissue mass in obese and aging rats. Am J Physiol Regul Integr
Comp Physiol. 2002;282:R890-R899.
Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC Growth
Charts for the United States: methods and development. Vital
Health Stat. 2002;11:1-190.
Ogden CL, Carroll MD, Lawman HG, et al. Trends in obesity prevalence among children and adolescents in the United States, 1988–
1994 through 2013–2014. JAMA. 2016;315:2292-2299.
Bi C, Leeder JS. Large-Scale Computation of Pediatric Growth
Percentiles with Fuzzy Logic Justification of Parameter Selection.
Proceedings of the 2012 IEEE Computational Intelligence
Symposium on Bioinformatics & Computational Biology
(CIBCB). 2012: 43-46.
Haycock GB, Schwartz GJ, Wisotsky DH. Geometric method for
measuring body surface area: a height-weight formula validated in
infants, children, and adults. J Pediatr. 1978;93:62-66.
Dubois D, Dubois E. A formula to estimate the approximate
surface area if height and weight be known. Arch Intern Med.
1916;17:863-871.
Peters AM, Snelling HL, Glass DM, Bird NJ. Estimation of lean
body mass in children. Br J Anaesth. 2011;106:719-723.
Al-Sallami HS, Goulding A, Grant A, et al. Prediction of Fat-Free
Mass in Children. Clin Pharmacokinet. 2015;54:1169-1178.
Park CW, Yu N, Yun SW, et al. Measurement and estimation of
renal size by computed tomography in Korean children. J Korean
Med Sci. 2017;32:448-456.
Lizarraga-
Mollinedo E, Martinez-
Calcerrada JM, Padros-
Fornieles C, et al. Renal size and cardiovascular risk in prepubertal
children. Sci Rep. 2019;9:5265.
Meyer-Gerspach AC, Peterli R, Moor M, et al. Quantification of
liver, subcutaneous, and visceral adipose tissues by MRI before
and after bariatric surgery. Obes Surg. 2019;29:2795-2805.
Gils Contreras A, Bonada Sanjaume A, Montero Jaime M, et al.
Effects of two preoperatory weight loss diets on hepatic volume,
metabolic parameters, and surgical complications in morbid obese

HOSEY-COJOCARI et al.

30.

31.

32.

33.

34.

35.

36.

37.
38.

39.

40.

bariatric surgery candidates: a randomized clinical trial. Obes
Surg. 2018;28:3756-3768.
Haddad S, Restieri C, Krishnan K. Characterization of age-related
changes in body weight and organ weights from birth to adolescence in humans. J Toxicol Environ Health A. 2001;64:453-464.
Kanamori M, Takahashi H, Echizen H. Developmental changes
in the liver weight-and body weight-
normalized clearance of
theophylline, phenytoin and cyclosporine in children. Int J Clin
Pharmacol Ther. 2002;40:485-492.
Noda T, Todani T, Watanabe Y, Yamamoto S. Liver volume in
children measured by computed tomography. Pediatr Radiol.
1997;27:250-252.
Takahashi H, Ishikawa S, Nomoto S, et al. Developmental changes
in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children. Clin Pharmacol Ther. 2000;68:541-555.
Heinemann A, Wischhusen F, Puschel K, Rogiers X. Standard
liver volume in the Caucasian population. Liver Transpl Surg.
1999;5:366-368.
Davidson LE, Kelley DE, Heshka S, et al. Skeletal muscle and
organ masses differ in overweight adults with type 2 diabetes. J
Appl Physiol. 2014;1985(117):377-382.
Barter ZE, Tucker GT, Rowland-Yeo K. Differences in cytochrome
p450-mediated pharmacokinetics between Chinese and Caucasian
populations predicted by mechanistic physiologically based pharmacokinetic modelling. Clin Pharmacokinet. 2013;52:1085-1100.
Wang J, Li B, Chen R. Reference values of main internal organs for
Chinese. Chinese J Radiol Med Protection. 1995;15:248-254.
Li GF, Zheng QS, Yu Y, et al. Impact of ethnicity-specific hepatic microsomal scaling factor, liver weight, and cytochrome
P450 (CYP) 1A2 content on physiologically based prediction
of CYP1A2-
mediated pharmacokinetics in young and elderly
Chinese adults. Clin Pharmacokinet. 2019;58:927-941.
Schmidt IM, Mølgaard C, Main KM, Michaelsen KF. Effect of
gender and lean body mass on kidney size in healthy 10-year-old
children. Pediatr Nephrol. 2001;16:366-370.
Morgan DJ, Bray KM. Lean body mass as a predictor of drug
dosage. Implications for drug therapy. Clin Pharmacokinet.
1994;26:292-307.

SUPPORTING INFORMATION
Additional supporting information may be found online in
the Supporting Information section.

How to cite this article: Hosey-Cojocari C, Chan SS,
Friesen CS, et al. Are body surface area based estimates
of liver volume applicable to children with overweight
or obesity? An in vivo validation study. Clin Transl Sci.
2021;14:2008–2016. https://doi.org/10.1111/cts.13059

